Terence H. Stern, MBA - Vice President Business Development
Mr. Stern is a multi-lingual, global executive with a broad record of entrepreneurial achievement across the healthcare arena spanning startups to large corporate entities. In 2010 Mr. Stern partnered with Mr. Hanley to develop detailed investment theses and financial models for clients in collaboration with leading healthcare-focused private equity firms.
In 2012 upon the inception of MediBeacon Mr. Stern joined Dr. Dorshow and Mr. Hanley as Vice President Business Development for the Company. Mr. Stern is responsible for MediBeacon’s finances in addition to his business development role.
As CEO and Founder of Vetbrands International, he led the private equity-backed management buyout of Ralston Purina’s pharmaceutical business. Cargill owned assets were acquired and combined with an independently owned pharmaceutical / R&D facility in Brazil. The successful orchestration of multiple acquisitions and the subsequent merger, integration, and growth led to the sale of this top ten Brazilian animal pharmaceutical business to Ceva Santé Animale (global animal health company with revenues of over $1 billion).
Mr. Stern has held various financial and corporate development roles based both in the US and Europe. These include work at Novus International where under his direction the Company’s leading global nutrition specialty business profitably doubled sales through organic growth, completed a bolt-on acquisition and entered a joint venture on a human supplement ingredient.
Mr. Stern is fluent in French, Portuguese, and Spanish. He has his bachelor’s degree from Colgate University and a master’s degree in business administration from Washington University in St. Louis.